EUVIMEDEUVIMED entdecken
Crossref

Comparison of Analgesic Effect of 0.4 mg versus 0.8 mg Intrathecal Nalbuphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries: A Randomized Double-Blind Study

Sandeep Kumar Sharma, Rajbala Rajbala, Santosh Kanwar

International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)

DOI: 10.25258/ijcpr.18.4.154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Sandeep Kumar Sharma und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intrathecal adjuvants are widely used to enhance the quality and duration of spinal anaesthesia. Nalbuphine, a mixed opioid agonist-antagonist, has shown promising results in improving postoperative analgesia with minimal side effects.

Objective

To compare the analgesic efficacy of intrathecal nalbuphine 0.4 mg versus 0.8 mg as an adjuvant to 0.5% hyperbaric bupivacaine in lower abdominal surgeries.

Methods

This randomized double-blind interventional study included 60 patients (ASA I–II) undergoing elective lower abdominal surgeries. Patients were divided into two groups (n=30 each): Group A received 0.4 mg nalbuphine and Group B received 0.8 mg nalbuphine with 0.5% hyperbaric bupivacaine intrathecally. Parameters assessed included onset and duration of sensory and motor block, duration of analgesia, Visual Analog Scale (VAS), hemodynamic variables, and adverse effects.

Results

Demographic parameters were comparable between groups. Onset of sensory and motor block showed no significant difference (p>0.05). However, duration of analgesia was significantly prolonged in Group B (278.03 ± 7.48 min) compared to Group A (236.83 ± 9.84 min) (p

Zitieren

APA

Sharma, S. K., Rajbala, R., & Kanwar, S. (2026). Comparison of Analgesic Effect of 0.4 mg versus 0.8 mg Intrathecal Nalbuphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries: A Randomized Double-Blind Study. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.154

Vancouver

Sharma SK, Rajbala R, Kanwar S. Comparison of Analgesic Effect of 0.4 mg versus 0.8 mg Intrathecal Nalbuphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries: A Randomized Double-Blind Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.154

BibTeX
@article{Sharma2026,
  author = {Sharma, Sandeep Kumar and Rajbala, Rajbala and Kanwar, Santosh},
  title = {Comparison of Analgesic Effect of 0.4 mg versus 0.8 mg Intrathecal Nalbuphine as an Adjuvant to 0.5% Hyperbaric Bupivacaine in Lower Abdominal Surgeries: A Randomized Double-Blind Study},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {04},
  doi = {10.25258/ijcpr.18.4.154}
}
Kostenlos starten →